Regulatory issues for plant-made pharmaceuticals and vaccines

Expert Review of Vaccines

Volumn 4, Issue 4, 2005, Pages 591-601

  Streatfield, Stephen J ^a  

^a Applied Biotechnology Institute   (United States)

Author keywords

Animal and Plant Health Inspection Service (APHIS); Biotechnology Regulatory Services (BRS); Containment; Manufacture of biologics; Oral vaccines; Plant based vaccines; Plant made pharmaceuticals; Risk assessment; US Department of Agriculture

Indexed keywords

RECOMBINANT VACCINE;

BIOTECHNOLOGY; COST CONTROL; DRUG DELIVERY SYSTEM; DRUG PURIFICATION; ENVIRONMENTAL EXPOSURE; FOOD CHAIN; HEALTH HAZARD; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK ASSESSMENT; TRANSGENIC PLANT; VACCINE PRODUCTION;

ANIMALS; BIOREACTORS; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; PLANTS, GENETICALLY MODIFIED; TECHNOLOGY, PHARMACEUTICAL; UNITED STATES; VACCINES, EDIBLE;

EID: 24744466107     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.4.4.591     Document Type: Review

References (48)

1. Peterson RKD, Arntzen CJ. On risk and plant-based biopharmaceuticals. Trends Biotechnol. 22, 64-66 (2004). Commentary on risk analysis of plant-made pharmaceuticals.
2. Howard JA, Donnelly KC. A quantitative safety assessment model for transgenic protein products produced in agricultural crops. J. Agric. Environ. Ethics 17, 545-558 (2004). Risk analysis applied to plant-made pharmaceuticals.
3. Nakamura S, Takasaki H, Kobayashi K, Kato A. Hyperglycosylation of hen egg white lysozyme in yeast. J. Biol. Chem. 268, 12706-12712 (1993).
4. Ward PP, Chu H, Zhou X, Conneely OM. Expression and characterization of recombinant murine lactoferrin. Gene 204, 171-176 (1997).
5. Tomiya N, Narang S, Lee YC, Betenbaugh MJ. Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines. Glycoconj. J. 21, 343-360 (2004).
6. Brooks SA. Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system. Mol. Biotechnol. 28, 241-255 (2004).
7. Hood EE, Woodard SL, Horn ME. Monoclonal antibody manufacturing in transgenic plants-mydis and realities. Curr. Opin. Biotechnol. 13, 630-635 (2002).
8. Zhong G-Y, Peterson D, Delaney DE et al. Commercial production of aprotinin in transgenic maize seeds. Mol. Breed. 5, 345-356 (1999).
9. Woodard SL, Mayor JM, Bailey MR et al. Maize-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol. Appl. Biochem. 37, 1-8 (2003). Report of enzyme expression in corn seed for commercialization.
10. Lamphear BJ, Streatfield SJ, Jilka JM et al. Delivery of subunit vaccines in maize seed. J. Control. Release 85, 169-180 (2002).
11. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Med. 4, 607-609 (1998). First clinical trial for a plant-made vaccine.
12. Kapusta J, Modelska A, Pniewski T et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13, 1796-1799 (1999).
13. Tacket, CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182, 302-305 (2000).
14. Yusibov V, Hooper DC, Spitsin SV et al. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20, 3155-3164 (2002).
15. Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22, 4385-4389 (2004).
16. Thanavala Y, Mahoney M, Pal S et al. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl Acad. Sci. USA 102, 3378-3382 (2005).
17. Howard JA, Hood E. Bioindustrial and biopharmaceutical products produced in plants. Advances in Agronomy 85, 91-124 (2005). Comparison of plant production systems.
18. Shah MM, Fujiyama K, Flynn CR, Joshi L. Sialylated endogenous glycoconjugates in plant cells. Nature Biotechnol. 21, 1470-1471 (2003).
19. Hood EE, Witcher DR, Maddock S et al. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol. Breed. 3, 291-306 (1997).
20. Rasmussen JR. Glycosylation of recombinant proteins. In: Biology of Carbohydrates. Ginsburg V, Robbins PW (Eds). JAI Press Ltd, Greenwich, CT, USA, 179-285 (1991).
21. van Ree R, Cabanes-Macheteau M, Akkerdaas J et al. β(1,2)-xylose and α(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J. Biol. Chem. 275, 11451-11458 (2000).
22. Chargelegue D, Vine ND, van Dolleweerd CJ, Drake PM, Ma JK. A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Res. 9, 187-194 (2000).
23. Wenderoth I, von Schaewen A. Isolation and characterization of plant N-acetyl glucosaminyltransferase I (GntI) cDNA sequences. Functional analyses in the Arabidopsis cgl mutant and in antisense plants. Plant Physiol. 123, 1097-1108 (2000).
24. Bakker H, Bardor M, Molthoff JW et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl Acad. Sci. USA 98, 2899-2904 (2001).
25. Streatfield SJ, Mayor JM, Barker DK et al. 2000 congress symposium on molecular farming: development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. Vitro Cell. Dev. Biol., Plant 38, 11-17 (2002).
26. Kusnadi AR, Nikolov ZL, Howard JA. Production of recombinant proteins in transgenic plants: practical considerations. Biotechnol. Bioeng. 56, 473-484 (1997).
27. Yuan Q, Hu W, Pestka JJ, He SY, Hart LP. Expression of a functional antizearalenone single-chain Fv antibody in transgenic Arabidopsis plants. Appl. Environ. Microbiol. 66, 3499-3505 (2000).
28. Menkhaus TJ, Bai Y, Zhang C, Nikolov ZL, Glatz CE. Considerations for the recovery of recombinant proteins from plants. Biotechnol. Prog. 20, 1001-1014 (2004).
29. Hiatt A, Cafferkey R, Bowdish K. Production of antibodies in transgenic plants. Nature 342, 76-78 (1989).
30. Huang Z, Elkin G, Maloney BJ et al. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 23, 1851-1858 (2005).
31. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl Acad. Sci. USA 93, 5335-5340 (1996).
32. Borisjuk NV, Borisjuk LG, Logendra S, Petersen F, Gleba Y, Raskin I. Production of recombinant proteins in plant root exudates. Nat. Biotechnol. 17, 466-469 (1999).
33. Fischer R, Liao YC, Drossard J. Affinity purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture. J. Immunol. Methods 226, 1-10 (1999).
34. Torres E, Vaquera C, Nicholson L et al. Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Res. 8, 441-449 (1999).
35. Twyman RM, Schillberg S, Fischer R. Transgenic plants in the biopharmaceutical market. Expert Opin. Emerg. Drugs 10, 185-218 (2005).
36. Daniell H, Khan MS, Allison L. Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci. 7, 84-91 (2002). Explains the chloroplast expression system.
37. Vaquero C, Sack M, Chandler J et al. Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves. Proc. Natl Acad. Sci. USA 96, 11128-11133 (1999).
38. Dalsgaard K, Uttenthal A, Jones TD et al. Plant-derived vaccine protects target animals against a viral disease. Nature Biotechnol. 15, 248-252 (1997). Early example of a plant viral expression system.
39. Streatfield SJ, Howard JA. Plant production systems for vaccines. Expert Rev. Vaccines 2, 763-775 (2003).
40. Kristinsson JB. Letter to the editor. Nature Biotechnol. 22, 508 (2004).
41. Bullerman LB. Occurrence of Fusarium and fumonisins on food grains and in foods. Adv. Exp. Med. Biol. 392, 27-38 (1996).
42. Padidam M. Chemically regulated gene expression in plants. Curr. Opin. Plant Biol. 6, 169-177 (2003).
43. Yang D, Guo F, Liu B, Huang N, Watkins SC. Expression and localization of human lysozyme in the endosperm of transgenic rice. Planta 216, 597-603 (2003).
44. Parmenter DL, Boothe JG, van Rooijen GJ, Yeung EC, Moloney MM. Production of biologically active hirudin in plant seeds using oleosin partitioning. Plant Mol. Biol. 29, 1167-1180 (1995).
45. Mariani C, Goldberg RB, Leemans J. Engineered male sterility in plants. Symp. Soc. Exp. Biol. 45, 271-279 (1991).
46. Zaitlin D, Chambers OD, Li B, Mundell RE, Davies HM. Letter to the editor. Nature Biotechnol. 22, 507 (2004).
47. Gleave AP, Mitra DS, Mudge SR, Morris BA. Selectable marker-free transgenic plants without sexual crossing: transient expression of ere recombinase and use of a conditional lethal dominant gene. Plant Mol. Biol. 40, 223-235 (1999).
48. Nikolov ZL, Woodard SL. Downstream processing of recombinant proteins from transgenic feedstock. Curr. Opin. Biotechnol. 15, 479-486 (2004).